别嘌醇与心力衰竭中的内皮功能：是未来的方向还是幻想？ - Suppr

Suppr

超能文献

Allopurinol and endothelial function in heart failure: future or fantasy?

作者信息

Landmesser Ulf, Drexler Helmut

出版信息

Circulation. 2002 Jul 9;106(2):173-5. doi: 10.1161/01.cir.0000024270.37833.f9.

DOI:10.1161/01.cir.0000024270.37833.f9

PMID:12105153

Abstract

摘要

相似文献

Allopurinol and endothelial function in heart failure: future or fantasy?

Circulation. 2002 Jul 9;106(2):173-5. doi: 10.1161/01.cir.0000024270.37833.f9.

Allopurinol improves endothelial dysfunction in chronic heart failure.

Circulation. 2002 Jul 9;106(2):221-6. doi: 10.1161/01.cir.0000022140.61460.1d.

Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies.

Circulation. 2002 Jun 4;105(22):2619-24. doi: 10.1161/01.cir.0000017502.58595.ed.

Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress.

Vasc Health Risk Manag. 2009;5(1):265-72. doi: 10.2147/vhrm.s4265. Epub 2009 Apr 8.

Xanthine oxidase inhibitors: an emerging class of drugs for heart failure.

Eur Heart J. 2005 Aug;26(15):1458-60. doi: 10.1093/eurheartj/ehi321. Epub 2005 May 25.

Allopurinol and endothelial function: A systematic review with meta-analysis of randomized controlled trials.

Cardiovasc Ther. 2018 Aug;36(4):e12432. doi: 10.1111/1755-5922.12432. Epub 2018 May 24.

The effects of xanthine oxidase inhibitor in patients with chronic heart failure complicated with hyperuricemia: a prospective randomized controlled clinical trial of topiroxostat vs allopurinol-study protocol.

Clin Exp Nephrol. 2018 Dec;22(6):1379-1386. doi: 10.1007/s10157-018-1599-6. Epub 2018 Jun 18.

Xanthine-oxidase inhibitors and statins in chronic heart failure: effects on vascular and functional parameters.

J Heart Lung Transplant. 2011 Apr;30(4):408-13. doi: 10.1016/j.healun.2010.10.003. Epub 2010 Dec 8.

Can Xanthine Oxidase Inhibitors Improve Cardiac Function in Patients With Chronic Heart Failure?

Int Heart J. 2016 Dec 2;57(6):661-662. doi: 10.1536/ihj.16-480. Epub 2016 Nov 4.

Effect of long-term and high-dose allopurinol therapy on endothelial function in normotensive diabetic patients.

Blood Press. 2011 Jun;20(3):182-7. doi: 10.3109/08037051.2010.538977. Epub 2010 Dec 7.

引用本文的文献

The Role of Antioxidants in the Therapy of Cardiovascular Diseases-A Literature Review.

Nutrients. 2024 Aug 6;16(16):2587. doi: 10.3390/nu16162587.

Allopurinol Lowers Serum Urate but Does Not Reduce Oxidative Stress in CKD.

Antioxidants (Basel). 2022 Jun 29;11(7):1297. doi: 10.3390/antiox11071297.

Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis.

Lancet Diabetes Endocrinol. 2016 Apr;4(4):327-36. doi: 10.1016/S2213-8587(15)00386-1. Epub 2016 Jan 16.

Clinical risk factors demonstrate an age-dependent relationship with oxidative stress biomarkers in African Americans.

Ethn Dis. 2010 Autumn;20(4):403-8.

Effects of allopurinol on cardiac function and oxidant stress in chronic intermittent hypoxia.

Sleep Breath. 2010 Feb;14(1):51-7. doi: 10.1007/s11325-009-0279-x. Epub 2009 Jul 15.

Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.

Pharmacol Rev. 2006 Mar;58(1):87-114. doi: 10.1124/pr.58.1.6.

Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure.

Heart. 2005 Jun;91(6):749-53. doi: 10.1136/hrt.2004.040477.

Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment.

Heart. 2004 Jul;90(7):765-70. doi: 10.1136/hrt.2003.017368.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验